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Structural Basis of Proline-Specific
Exopeptidase Activity as Observed
in Human Dipeptidyl Peptidase-IV
tion and proliferation (von Bonin et al., 1998) by interac-
tion with the protein tyrosine phosphatase (CD45) (Tori-
moto et al., 1991).
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4070 Basel X-alanine dipeptides from the N terminus of polypep-
tides (Cunningham and O’Connor, 1997; Hopsu-HavuSwitzerland
and Glenner, 1966). It belongs to the prolyl oligopepti-
dase family, a group of atypical serine proteases able to
hydrolyze the prolyl bond (Cunningham and O’Connor,Summary
1997) with the sequential order of the catalytic residues
Ser-Asp-His (Ikehara et al., 1994), inverse to that foundInhibition of dipeptidyl peptidase IV (DPP-IV), the main
in classical serine proteases (His-Asp-Ser). The cleav-glucagon-like peptide 1 (GLP1)-degrading enzyme,
age of N-terminal peptides with Pro in the second posi-has been proposed for the treatment of type II diabe-
tion is a rate-limiting step in the degradation of peptides.tes. We expressed and purified the ectodomain of hu-
The natural substrates of DPP-IV include several chemo-man DPP-IV in Pichia pastoris and determined the
kines, cytokines, neuropeptides, circulating hormones,X-ray structure at 2.1 A˚ resolution. The enzyme con-
and bioactive peptides (Lambeir et al., 2001). The widesists of two domains, the catalytic domain, with an
range of substrates suggests a key regulatory role in/ hydrolase fold, and a  propeller domain with an
the metabolism of peptide hormones and in amino acid8-fold repeat of a four-strand  sheet motif. The
transport (Hildebrandt et al., 2000). Its physiological rele- propeller domain contributes two important func-
vance has been investigated by Augustyns et al. (1999),tions to the molecule that have not been reported for
Hinke et al. (2000), Holst and Deacon (1998), and Ment-such structures, an extra  sheet motif that forms part
lein (1999).of the dimerization interface and an additional short
The finding that DPP-IV is responsible for more thanhelix with a double Glu sequence motif. The Glu motif
95% of the degradation of GLP-1 led to an elevatedprovides recognition and a binding site for the N termi-
interest in inhibition of this enzyme for the treatment ofnus of the substrates, as revealed by the complex
type II diabetes. Experiments in rats and humans havestructure with diprotin A, a substrate with low turnover
provided evidence that specific DPP-IV inhibition in-that is trapped in the tetrahedral intermediate of the
creased half-life and total circulating GLP-1 and de-reaction in the crystal.
creased plasma glucose. It has been demonstrated that
patients with impaired glucose tolerance (IGT), type II
Introduction diabetes, and a secondary failure to respond to sulfonyl-
urea treatment benefit from increased levels of GLP1
Dipeptidyl peptidase (DPP-IV; T cell activation antigen peptides. In addition, GLP-1 is effective in type I diabetic
CD26, or adenosine binding protein) is a multifunctional patients because of its glucagonostatic effect. More re-
type II cell surface glycoprotein. The protein is widely cent investigations show a delay of gastric emptying
expressed in a variety of cell types, particularly on differ- that could have beneficial effects on satiety and might
ential epithelial cells of the intestine, liver, prostate tis- be relevant for the treatment of obesity. Protection of
sue, corpus luteum, and kidney proximal tubules (Hartel functional GLP-1 by inhibition of DPP-IV and concomi-
et al., 1988; McCaughan et al., 1990) as well as leukocyte tant activation of the GLP-1 receptor might therefore
subsets (Gorrell et al., 1991), such as T-helper lympho- have a synergistic potential in antidiabetic drug research
cytes, and subsets of macrophages (Bu¨hling et al., (Holst and Deacon, 1998). Selective and orally available
1994), and a soluble form is reported to be present in small molecule inhibitors of DPP-IV have been discov-
plasma and urine (Iwaki-Egawa et al., 1998). Human ered and are now in clinical trials (Pospisilik et al., 2002;
DPP-IV has a short cytoplasmatic tail of 6 amino acids, Villhauer et al., 2002).
a 22-amino acid hydrophobic transmembrane region, We expressed and purified the ectodomain of human
and a 738-amino acid extracellular domain with ten po- DPP-IV in Pichia pastoris and determined the X-ray
tential glycosylation sites (Tanaka et al., 1992). structure at 2.1 A˚ resolution in order to support and
DPP-IV has roles in many biological processes, in- accelerate drug discovery activities by structure-based
cluding a membrane-anchoring function for the localiza- drug design and functional analysis. The enzyme con-
tion of the extracellular enzyme adenosine deaminase sists of two domains, the catalytic domain, with an /
(ADA) (Franco et al., 1998), participation in cell matrix hydrolase fold, and a  propeller domain with an 8-fold
adhesion by binding to collagen and fibronectin (Loster repeat of a  sheet motif that consists of four antiparallel
et al., 1995; Piazza et al., 1989), interaction as a corecep- strands. The  propeller domain contributes two impor-
tor for the HIV envelope protein gp 120 (Ohtsuki et al., tant functions to the molecule that have not been re-
2000), and a costimulatory function during T cell activa- ported for such structures, an extra  sheet motif that
forms part of the dimerization interface and an additional
short helix with a double Glu sequence motif. The Glu*Correspondence: michael.hennig@roche.com
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triad (Ser630, Asp708, and His740), and a domain withTable 1. Enzyme Kinetic Constants of DPP-IV
an eight-bladed  propeller fold, the  propeller domain
Proteins kcata (s1) KMa (M) kcat/KM(M1s1) (Figure 2). The assignment of the secondary structure
sDPP-IVdeglycos 43.1 17.2 2.51 is given in Figures 1 and 2. The only other known crystal
sDPP-IVglycos 37.3 15.5 2.41 structure of this class of enzyme is that of prolyl-oligo-
sDPP-IVdeglycos/ADA 39.6 14.8 2.68 peptidase (POP), determined by Fu¨lo¨p et al. (1998) (Pro-
a Analyzed with Lineweaver-Burk plots; buffer, 50 mM Tris-HCl (pH tein Data Bank entry 1qfm). POP has an /-hydrolase
7.8), containing 100 mM NaCl, 0.1 mg/ml BSA, and 0.5% dimethyl- and a  propeller domain, as well, but is monomeric,
formamid; substrate, Ala-Pro-7-amido-4-trifluoromethylcoumarin; and the  propeller consists of seven repeats only (Fig-
temperature, 25C.
ure 3C).
During the review process of this manuscript, a report
describing the structure of human DPP-IV (Rasmussen
motif provides recognition and a binding site for the et al., 2003) in complex with another peptidic ligand
N terminus of the substrates, as revealed by the complex (valine-pyrrolidine dipeptide) was published. The authors
structure with diprotin A, a substrate with low turnover produced human DPP-IV in a baculovirus expression
that is trapped in the tetrahedral intermediate of the system and used the enzyme without deglycosylation
reaction in the crystal. for crystallization. The resulting crystals exhibit a differ-
ent crystal form, diffracting to 2.5 A˚ resolution. This
overall structure of the enzyme is essentially identicalResults and Discussion
to the one reported here.
Production and Purification of sDPP-IV
The soluble extracellular domain of human dipeptidyl Catalytic Domain
peptidase IV (sDPP-IV; residues 31–766) was expressed The catalytic domain is built up of residues Gln508–
in the yeast Pichia pastoris. The protein was secreted Pro766 and contains a central eight-stranded  sheet
at the low level of 1 mg/l, as estimated from the total that is flanked by 12 helices known as the / hydrolase
activity. As a first purification step, the concentrated fold. Twenty-one percent sequence identity to POP indi-
protein was passed through a size exclusion column, cates significant structural homology (Figure 1), and su-
which removed the main fraction of contaminating pep- perposition of the central  helix, carrying the catalytic
tides from the yeast-peptone medium. Sequential chro- Ser630 on its first turn, with the corresponding structure
matography on anion and cation exchanger columns of POP gives an rms deviation of 2.5 A˚2 for 238 residues.
and a second size exclusion chromatography were used The catalytic domain is connected to the  propeller by
to get protein of 95% purity, as judged by SDS-PAGE. an N-terminal 15-residue linker, which is considerably
The yield of pure protein was 0.3 mg/l of growth medium. shorter than the corresponding 76-residue region in
The purified protein shows essentially an identical KM POP. The residues lacking in DPP-IV are, however, re-
value and identical inhibition constants for known inhibi- placed structurally and functionally by the C-terminal
tors of DPP-IV, like NVP-DPP728 (Hughes et al., 1999), part of the catalytic domain of the second subunit of
to the enzyme from human serum (Tables 1 and 2). the dimer.
Overall Structure
 Propeller DomainThe structure of human DPP-IV was solved by MAD with
The  propeller domain is formed by residues Lys56–a mercury derivative (see Table 3) and subsequently
Asn497. The preceding N-terminal residues Ser39–refined to an R factor of 21.5% at 2.1 A˚ resolution. The
Leu55 form a loop structure with a small  helix (1*;current model consists of all residues from Ser39 to
Figure 1) at the surface and in close proximity to thePro766 of the amino acid sequence of the expressed
first residues of the catalytic domain. The  propellerectodomain of the protein.
domain consists of an 8-fold repeat of a four-strandedA homodimer of DPP-IV is situated in the asymmetric
antiparallel  sheet motif (blade; Figure 3A and 3B). Theunit (Figure 2). Dimerization is also observed in solution
blades are in circular arrangement, such that they formunder various conditions and is required for activity.
a solvent-filled tunnel with a diameter of about 13 A˚.Each subunit is made of two domains, the catalytic do-
The  propeller domain in DPP-IV does not form amain, with an / hydrolase fold containing the catalytic
joint  sheet motif (Fu¨lo¨p and Jones, 1999; Paoli, 2001),
but, rather, the blades show a regular arrangement (1/1
to 7/4 or 8/4) (Figure 3A) around the central axis,Table 2. KI and KD Values of DPP-IV Inhibitors
forming a ring system that is not closed.
KI (M) KD (M) kon (M1s1) koff (s1) DPP-IV deviates from the regular  propeller fold by
additional secondary-structural elements. An antiparal-Ile-Pro-Ile 4.63b 3.8a — —
NVP-DPP728 0.006b 0.002a 1.36  106 a 2.48  103 a lel  sheet is inserted in blade 2 between strands 1 and
NVP-DPP728(Lit.)c 0.011 0.010 1.3  105 1.3  103 2. The tip of the turn carries the residue, Arg125, that
forms a salt bridge with Glu205, which is situated at thea Measured with Biacore; buffer, 0.01 M Hepes (pH 7.4), containing
0.15 M NaCl, 3 mM EDTA, and 0.005% polysorbate 20 (v/v). C-terminal turn of an  helix (residues Trp201–Glu205),
b Temperature, 25C; in assay buffer (see Table 1); glycosylated which is inserted between the third and fourth blade.
sDPP-IV. Arg125, Glu205, and the neighboring Glu204 form a sig-
c (Hughes et al., 1999).
nificant part of the substrate binding site and are mainly
Crystal Structure of DPP-IV
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Table 3. Crystallographic Data and Refinement Statistics
MAD Diprotin A
Data Set MAD (Remote) MAD (Peak) (Inflection) Apo Complex
Wavelength 0.992 1.0065 1.009 0.9765 0.92
X-ray source SLS SLS SLS ID14, ESRF SLS
Detector MAR IPa MAR IPa MAR IPa Quantum CCD MAR CCD
Exposure time/frame (s) 10 10 10 2 4
Angular increment per frame () 2.0 2.0 2.0 0.25 0.25
Total rotation range () 110 136 140 130 130
Crystal to detector distance (mm) 410 410 410 240 260
Unit cell parameters (a, b, c) (A˚) 65.2, 68.7, 420.1 65.2, 68.7, 420.1 65.2, 68.7, 420.1 65.5, 68.2, 419.3 65.1, 67.1, 419.6
Data Reduction
Maximum Resolution (A˚) 2.6 2.6 2.6 2.1 2.5
Number of measurements 212,619 263,910 276,921 234,528 171,090
Number of unique reflections 58,627 59,544 59,939 87,113 64,208
Completeness (%)b 97.5 (99.4) 99.9 (100.0) 99.9 (99.9) 82.9 (72.3) 97.5 (99.4)
Rsymb,c 9.1 (15.9) 9.0 (18.1) 8.6 (14.2) 8.4 (26.8) 9.1(15.9)
Heavy-Atom Refinement Parameters
f(e) / f″(e) 7.0/9.5 8.0/9.8 12.1/5.0
Phasing powerd (anomalous) 0.95 1.0 0.7
Refinement Statistics
Resolution range (A˚) 20–2.1 30–2.5
Rcryst (Rfree)e (%) 21.5 (26.5) 22.5 (28.2)
Number of protein atomsf (mean B in A˚2) 11 962 (34.6) 11 962 (27.1)
Number of water molecules 322 (33.4) 268 (25.0)
Number of ligand/heavy atoms (mean B 6 (77.3) 24 (28.3)
in A˚2)
Number of NAG atoms (mean B in A˚2) 112 (59.0) 98 (51.4)
Rmsdg bonds (A˚2) 0.018 0.019
Rmsdg angles () 1.86 2.07
a mar research image plate detector (345 mm diameter, 100 m pixel size).
b Values in parentheses are statistics for the highest resolution bin.
c Rsym  	h	i|Ii(h)  
I(h)|/	h	i(h), where Ii(h) and 
I(h) are the ith and mean measurements of the intensity of reflection h.
d Phasing power  	hFH(h)/	h|FD(h)  |FN(h)  FH(h)||.
e	h ||Fobs|  |Fcalc||/	h|Fobs|, where |Fobs| and |Fcalc| are the observed and calculated structure factor amplitudes for the reflection h, applied to
the working (Rcryst) and test (Rfree) sets, respectively.
f Nonhydrogen atoms only.
g Rmsd, root-mean-square deviation from mean.
responsible for the substrate specificity. A further anti- for the substrate and product to access and leave the
active site, a cleft between the domains and the tunnelparallel  sheet motif formed by residues Asp230–
Asn263 is inserted between strands 3 and 4 of blade 4 through the  propeller. The open cleft may enable large
peptides and partially folded proteins to access the ac-(Figure 3B). This structural element forms a significant
part of the dimer interface (see below). tive site. The narrower tunnel could be an exit for the
cleaved dipeptides (Figure 4). The crystal structure ofWhereas the N-terminal  sheet structure of the pro-
peller has shorter strands and is somewhat tilted, the POP shows that the cleft between the two domains does
not exist and that the tunnel through the  propeller isloop connecting the first and second  sheet is longer,
shows high temperature factors, and may reduce the narrower, about 4 A˚ compared to about 13 A˚ for DPP-
IV (Figures 3A and 3C). This structural difference is sup-rigidity of the propeller architecture. The reduced stabil-
ity of the circular domain structure at this position might ported by the observation that DPP-IV can process
much larger substrates than can POP. Peptides with abe compensated by an extended hydrophobic cluster
that consists of Ile63, Leu69, Ile76, Phe89, Leu90, Phe95, length of up to about 80 residues appear to be good
substrates of DPP-IV, and larger proteins may also bePhe98, Ile107, Ile114, Tyr135, Leu137, and Leu142, a
salt bridge between Arg61 and Asp104, and a hydrogen cleaved, depending on their tertiary structures (Au-
gustyns et al., 1999; Mentlein, 1999). In contrast, POPbond between the main chain NH of Arg61 and Tyr105.
This distortion leads to a reduced height of the propeller is reported to hydrolyze substrates with a maximum size
of about 30 residues only (Polgar, 1992). As the diameterat the positions between blades 1 and 2 (Figure 3B).
As no residues from the / hydrolase domain fill of the  propeller tunnel in POP is significantly smaller,
substrate access in POP requires movement of the pro-this up, a cleft between the two domains of the DPP-
IV molecule is formed, with a diameter of about 15 A˚, peller blades (Fu¨lo¨p et al., 2000).
The  propeller motif has been found in several furtherenabling access to the catalytic site (Figure 4). There-
fore, we propose that DPP-IV has two independent ways proteins, but no, or only low, sequence homology could
Structure
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Figure 1. Sequence Alignment of DPP-IV and
POP
Amino acid sequence alignment of DPP-IV
from human (hDPP-IV) and rat (rDPP-IV; only
different residues are shown). The alignment
of POP from pork was performed with struc-
tural superposition for the /-hydrolase do-
main only because of a lack of structural ho-
mology for the  propeller domain. The top
line gives additional information about the
secondary structure of DPP-IV (yellow arrows
and red bars), the glycosylation sites with vis-
ible electron density (Y), the potential glyco-
sylation sites (red), the disulphide bonds
(green lines between cysteines that are in-
volved) and an arrow that indicates the start
of the cloned ectodomain. Sequences are
highlighted in light gray for the transmem-
brane part, gray for the part of the  propeller
involved in dimerization, green for residues
involved in adenosine deaminase binding,
blue for the tyrosine that is involved in the
stabilization of the oxyanion of the catalytic
intermediate, and pink for the catalytic res-
idues.
be demonstrated (Fu¨lo¨p and Jones, 1999; Jawad and Active Site
The catalytic triad (Ser630, Asp708, and His740) is lo-Paoli, 2002; Paoli, 2001). A search of the Protein Data
Bank for homologous structures gave proteins with very cated in a large cavity at the interface of the two do-
mains. Ser630 is found at the tip of a very sharp turndifferent functions, such as clathrin (seven blades; ter
Haar et al., 1998), methylamine dehydrogenase (seven between  strand 5 and helix C, called the nucleophile
elbow, which is a characteristic of hydrolases of the /blades; Chen et al., 1998) and nitrite reductase (eight
blades; Fu¨lo¨p et al., 1995). type (Ollis et al., 1992). The serine hydroxy group is
Crystal Structure of DPP-IV
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Figure 2. Overall Structure of DPP-IV
Ribbon diagram of DPP-IV viewed perpendicular to the 2-fold axis. The domains are colored dark green and light green for the / hydrolase
and  propeller domains, respectively, of subunit A and dark/light blue for the other subunit. The overall dimensions of the molecule are about
125  80  60 A˚3. The active site is highlighted by the catalytic residues in ball and stick representation as well as residues that are identified
by mutagenesis data to be important for ADA binding. The proposed location at the cell surface is shown by the schematic drawing of the
membrane. This figure was prepared with Molscript (Kraulis, 1991) and rendered with Raster3D (Merrit and Bacon, 1997).
well exposed to solvent and hydrogen bonded to the density map shows the ligand covalently bound to the
active site Ser630 of the enzyme in both subunits. Thecatalytic imidazole group of His740 on one side (2.6 A˚)
and accessible to the substrate on the other side. His740 N-terminal Ile (P2) and Pro residues (P1) are well defined
and enable a detailed analysis of the interaction withis found in the middle of a loop between  strand 8 and
helix F. With a distance of 2.75 A˚ to N of the imidazole the substrate binding site (according to the notation of
Schechter and Berger [1968]). Less well-defined elec-ring, one of the oxygen atoms of Asp708 is hydrogen
bonded to His740 and completes the catalytic triad (Fig- tron density is found for the C-terminal Ile (P1), but, in
subunit B, the conformation of this part of the ligandure 5). The other oxygen atom of the carboxylate group
of Asp708 is coordinated by two main chain NH groups could also be observed (Figure 5). The side chain N of
the catalytic His740 is in hydrogen bonding distance to(Val711 and Asn710). Thus, the location and geometry
of the triad are very similar to those found in other / the NH group of P1 (2.90 A˚) and to the O of the Ser630
side chain (2.83 A˚). The presence of the tripeptide in thehydrolases, with the “handedness” opposite to that of
the classical serine peptidases (Ollis et al., 1992). active site indicates a very slow hydrolysis rate that
might be different at the crystallization conditions com-The negatively charged oxyanion of the tetrahedral
intermediate is stabilized by the main chain NH group pared to published data (Rahfeld et al., 1991).
DPP-IV hydrolyzes oligopeptides and proteins fromof Tyr631 and by the hydroxy group of Tyr547 (Figure
5). Furthermore, the structure shows that Gly628 and the N terminus, cleaving dipeptide units when the sec-
ond residue is proline, hydroxyproline, dehydroproline,Gly632 are important for the formation of the sharp turn
to bring the catalytic residue Ser630 in the correct posi- pipecolic acid, or alanine. In both subunits the proline
in position P1 of diprotin A is in the trans-configurationtion. This is in accordance with mutagenesis studies on
rat DPP-IV (Ogata et al., 1992) showing that the se- and fits optimally into the pocket of the active site, as
expected (Fischer et al., 1983). The S1 pocket is formedquence Gly628-X-Ser630-Tyr631-Gly632 is essential for DPP-
IV activity. by Val711, Val656, Tyr662, Tyr666, Trp659, and Tyr631,
which shape a well-defined hydrophobic pocket that
would be filled by proline much better than by alanine.Substrate Binding
The substrate binding site of DPP-IV is indicated by the A major contribution to binding to the pyrrolidine ring
of Pro is achieved by ring stacking to Tyr662, which isbound diprotin A (Ile-Pro-Ile), which is a substrate with
a low turnover leading to an apparent competitive inhibi- equivalent to Trp595 in POP (Fu¨lo¨p et al., 1998). Gly is
also accepted, but with very low kcat/KM values (Brandttion (Rahfeld et al., 1991). Inspection of the electron
Structure
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Figure 3. Ribbon Drawing of the  Propeller Domains of DPP-IV and POP
(A) DPP-IV has eight repeats of a structural motif that consists of four antiparallel  strands or blades (blades are numbered 1–8). Additional
secondary structural elements are colored magenta: an antiparallel  sheet (2/2a and 2/2b in Figure 1) that is an extension of blade 2 with
Arg125 at the tip of the turn that is involved in the substrate binding, an  helix (2* in Figure 1) with the C-terminal glutamate-rich loop that
contributes to substrate recognition and specificity (Glu204/205/206), and the antiparallel  sheet that forms a main part of the dimer interface
(1* and 2* in Figure 1). The latter structural elements are extensions of blade 4.
(B) The  propeller domain of DPP-IV rotated 90.
(C) POP has seven blades and no notable deviations from the  propeller structure. The blades are numbered 1–7.
et al., 1995). No other naturally occurring amino acids in position by strong interactions with the carboxylates
of the double Glu motif, Glu205 and Glu206, as well asresidues can occupy position P1. Either the side chains
are too bulky or hydrophilic. The side chains of the resi- the OH of Tyr662 (Figure 5). A third glutamate, Glu204,
stabilizes this substrate recognition site by a hydrogendues P2 and P1point into the solvent, and no interaction
with the protein occurs. This explains the large diversity bonding network with the backbone NH of Arg125,
His126, and Ser127 as well as the hydroxy group ofof amino acids accepted in substrates at these posi-
tions. Ser127. The importance of the glutamate residues is
confirmed by single point mutations that abolish DPP-Essential for substrate binding and catalysis is the
N terminus of the substrates, which has to be unpro- IV activity (Abbott et al., 1999a). The double Glu motif
is located at the end of a helical segment (2*; Figuretected and protonated (Brandt et al., 1996; Heins et al.,
1988; Yoshimoto et al., 1978). The diprotin A complex 1; see also Figure 3) that is highly conserved in the DPP
IV-like gene family (Asp-Trp-X-Tyr-Glu-Glu-Glu-X). Theshows that the terminal NH3group is held very precisely
Crystal Structure of DPP-IV
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Figure 4. Access to the Active Site
Schematic view on the subunit of DPP-IV with
the active site surface colored according to
the atom types. The substrate diprotin A is
shown with white carbons indicating the sub-
strate binding site. Arrows illustrate that the
substrate may enter the active site at the well-
accessible and open active site cleft and that
the dipeptidic product of the catalytic reac-
tion may leave the active site cavity via the
narrower tunnel that is formed by the  pro-
peller.
helix represents a deviation from the regular  sheet drophobic interaction may stabilize the tripeptide in an
unsuitable conformation for the progress of the reaction.architecture of the  propeller domain (Figures 1 and
3A). A superposition of the active sites of the complexes Second, a large network of salt bridges and hydrogen
bonds stabilize the complex. It involves the carboxylof the exopeptidase DPP-IV with diprotin A and the en-
dopeptidase POP with an octapeptide (Fu¨lo¨p et al., groups of Glu205/206 that interact with the N terminus
of the tripeptide, but Glu205 makes another salt bridge2001) shows clear differences. The P3 and P4 residues
of the octapeptide substrate of POP coincide with the to Arg125, and this, in turn, interacts with the C-terminal
carboxyl group of the tripeptide (Figure 5). It is obviousdouble Glu motif in DPP-IV, indicating that this additional
structural element in the exopeptidase is very important that this interaction is only present in tripeptidic sub-
strates and may stabilize the observed intermediate byfor substrate selectivity. Thus, the double Glu motif is
a recognition site for the N terminus of substrates and protection of the leaving group.
We note that the pyrrolidine moieties of the structurerestricts the cleavage to dipeptides, and the S1 pocket
provides an optimal binding to proline and alanine resi- presented here and of the complex with the dipeptide
valine-pyrrolidine (Rasmussen et al., 2003) shift aboutdues, leading to a highly specific peptidase.
1 A˚, whereas the conformations of the active side resi-
dues are very similar. The observed differences can beMode of Inhibition by Diprotin A
attributed to the covalent and noncovalent binding ofInspection of the electron density of the bound inhibitor
the ligands to the enzyme, respectively.shows a covalent linkage to Ser630 and a tetrahedral
configuration for the C atom of the former carbonyl
group of the scissile peptide. Obviously, a tetrahedral Dimerization
Both the crystal structure and analytical ultracentrifuga-intermediate is observed in the complex structure with
the substrate diprotin A (Figure 5), with the oxyanion tion indicate dimeric oligomerization for deglycosylated
sDPP-IV, with a molecular weight of 169 kDa and non-stabilized by hydrogen bonds to the hydroxy group of
the side chain of Tyr547 (2.70 A˚) and the main chain crystallographic 2-fold symmetry (Figure 2). Six percent,
or 1837 A˚2, of the total solvent-accessible surface areaamine of Tyr631 (3.15 A˚). As much of the catalytic power
of serine proteases derives from its preferential binding of each subunit is buried in the dimer interface (XSAE
program, C. Broger, personal communication). This in-of this transition state, the tetrahedral intermediate is a
well-defined, but normally high-energy, state with a terface is mainly built up by two extra  strands (1*
and 2*) in the loop between strands 2 and 3 of theshort lifetime. The accumulation of this intermediate
could be a result of a kinetic barrier, and the inspection fourth blade of the  propeller domain (Figures 3A and
3B). Further interaction is provided by the / hydrolaseof the active site structure reveals several structural
features that could lead to a trapping of diprotin A. First, domain with helix E,  strand 8, and helix F, with
mainly hydrophobic interactions. The active site is verythe two hydrophobic isoleucine side chains point in the
same direction in proximity, and, therefore, this hy- close to this dimer interface (Figure 2), with His740 from
Structure
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Figure 5. Active Site of DPP-IV with Diprotin
A (Ile-Pro-Ile)
(A) The substrate diprotin A is trapped as a
tetrahedral intermediate covalently bound to
the active site Ser630. Bonds are dark blue
for the protein, light blue for the ligand, and
green for the active site Ser630. Dashed lines
indicate hydrogen bonds. This figure was
drawn with MOLOC (Gerber, 1992).
(B) The insert shows the ligand and Ser630
with the omit electron density superimposed
(atoms shown were omitted from the calcula-
tions) contoured at 2.5  (green) and 4 
(yellow).
the catalytic triad located in the loop connecting F Cys385/Cys394, Cys454/Cys472, and Cys328/Cys339).
One disulfide bond is observed in the /-hydrolaseand 7 (Figure 1). Consequently, disruption of the dimer
domain (Cys649/Cys762) and covalently links the C-ter-interface would also strongly affect the catalytic activity,
minal helix F to the core of the / hydrolase domain.and dimerization is required for activity.
Glycosylation
Stability of DPP-IV sDPP-IV overexpressed in P. pastoris shows a decreas-
As a cell surface protein, DPP-IV is extremely stable. ing molecular weight over the elution peak in the analyti-
Consequently, the recombinant sDPP-IV shows a half- cal gel filtration, as analyzed online with a multiangle
life of 5 min at 71C in irreversible heat inactivation ex- laser light-scattering detector. In contrast, sDPP-IV degly-
periments, independent of the protein concentration cosylated with EndoF glycosidase shows a uniform molec-
and the degree of glycosylation, indicating high thermal ular weight over the whole peak range because of the
stability. In unfolding experiments (Lambeir et al., 1997) specific cleavage of asparagines-linked oligomannose
with protein purified from human seminal plasma, DPP- after the first N-acetylglucosamines residue (GlcNAc). This
IV retained its native conformation up to 8 M urea. leads to a decrease in molecular weight of 20 kDa, as
The crystal structure points to several factors that estimated by SDS-PAGE. Crystals suitable for X-ray dif-
may contribute to this stability. First, the structural orga- fraction have been observed with protein that was
nization as a dimer with an extended hydrophobic inter- treated with Endo F. Four GlcNAc’s at the positions
face stabilizes the molecule, as shown for several other Asn85, Asn150, Asn229, and Asn281 could be identified
proteins (Thoma et al., 2000). Second, we observed five in subunit A. In subunit B, the GlcNAc connected to
disulphide bonds and two free sulfhydryl groups by SH Asn85, Asn150, and Asn229 is again visible, and an
titration experiments under denaturing conditions that additional site could be identified at Asn92, but no elec-
have now been confirmed by the X-ray structure. All tron density for an GlcNAc was found for Asn281. The
disulphide bridges in the  propeller connect different GlcNAc of Asn85 is involved in a crystal contact in both
subunits.strands in blades or stabilize loops (Cys444/Cys447,
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DPP-IV expressed in human has a more complex type tion with HIV proteins (Ohtsuki et al., 2000), and costimu-
latory function during T cell activation (von Bonin et al.,of glycosylation than in P. pastoris (Cremata et al., 1998)
and contains terminal sialic acid (Lambeir et al., 1997). 1998). With its unique substrate specificity, cleaving off
X-Pro or X-Ala dipeptides from the N terminus, DPP-IVHowever, no change in catalytic parameters (see Table
2) or folding is expected. plays a critical role in initiating N-terminal degradation
of bioactive peptides in endocrine, neuroendocrine, and
immune functions (Augustyns et al., 1999; Hinke et al.,Interaction with ADA
2000; Holst and Deacon, 1998; Mentlein, 1999). Inhibi-Adenosine deaminase (ADA; EC 3.5.4.4) is a 41 kDa
tion of DPP-IV leads to an increased half-life of GLP-1protein expressed in all mammalian tissues that cata-
(von Bonin et al., 1998), corresponding to a GLP-1 aug-lyzes the deamidation of adenosine and 2-deoxyadeno-
mentation and stimulation of insulin secretion. DPP-IVsine to inosine and 2-deoxyinosine, respectively. It is
has therefore been selected as a target for the treatmentimportant for the regulation of the extracellular concen-
of type II diabetes. The structure of DPP-IV and its com-tration of adenosine and for the regulation of the immune
plex with the tripeptide Ile-Pro-Ile will provide essentialresponse. ADA is involved in T cell activation in general,
information to drug discovery, as it explains how sub-and the pathogensis of autoimmune disorders (such as
strates are specifically recognized and gives insightsrheumatoid arthritis) as well as the mechanism of immu-
into key interactions that can be used for the inhibitionnodeficiency disease (such as SCID or AID; Franco et
of the catalytic activity. Two specific negative chargesal., 1998). Binding of the soluble extracellular ADA is a
from the double Glu sequence motif guide the N termi-unique property of DPP-IV molecules of higher mam-
nus of the peptide to the active site and fix the substratemals and is not observed in mouse or rat DPP-IV (Dinjens
in the correct position for cleavage. The distance be-et al., 1989; Iwaki-Egawa et al., 1997). Using analytical
tween the double Glu and the catalytic serine limits theultracentrifugation, we observed a 1:1 complex of ADA
cleavage to dipeptides, and the size and shape of themolecules with a sDPP-IV subunit, giving a molecular
P1 pocket restricts the S1 residue to proline or with lessweight of 252 kDa. Surface plasmon resonance (Biacore)
affinity to alanine—valuable information for the designmeasurements show a binding constant of 3.15  2 nM
of new inhibitors (Augustyns et al., 1999; Hinke et al.,to ADA from bovine with a very low dissociation rate
2000; Holst and Deacon, 1998; Mentlein, 1999). The ap-(koff 8.75 105 s1; kon 2.98 104 M1s1), indicating parent competitive inhibition caused by a low turnovera strong interaction.
rate of the substrate Ile-Pro-Ile can be explained byMutagenesis studies (Abbott et al., 1999b; Dong et
the trapping of the tetrahedral intermediate by severalal., 1997) identified two important regions in DPP-IV,
interactions that cannot be expected for normal sub-Leu340-Val341-Ala342-Arg343 (at the beginning of 5/4) and strates. In particular, the hydrophobic interactions madeLeu294 (4, at the end of blade 4), and a less important
by the Ile side chains of the ligand and participation ofregion, Glu332-Ser333-Ser334-Gly335-Arg336 (a loop region at the negatively charged C terminus of the peptide inthe end of 5/3), that are all located at the surface of
an extensive salt bridge cluster account for this kineticthe  propeller domain (Figure 1). Mutation to amino
barrier.acids found in rat DPP-IV reduces binding affinity to
Besides the impact for drug design, the structureADA. These residues form a binding site that is located
gives an understanding of the importance of dimeriza-far away from the active site (Figure 2), confirming the
tion for DPP-IV activity, the regulation of substrate ac-independence of DPP-IV activity on ADA binding (Table
cess via two active site entrances, and the interaction1; De Meester et al., 1994). We conclude that the function
with other proteins, such as adenosine deaminase.of DPP-IV is the localization and orientation of ADA for
proper catalysis. The structure gives an indication for
Experimental Procedures
the orientation and localization at the cell surface, be-
cause the N terminus must be close to the membrane DNA Manipulation and Sequence Analysis
and the ADA binding would be on the opposite site Preparation of DNA probes, digestion with restriction endonucle-
ases, DNA ligation, and transformation of E.coli strains were per-of the molecule—pointing away from the cell surface
formed as described (Sambrook et al., 1989). For DNA sequencing,(Figure 2). Further, there would be sufficient space en-
the ABI PRISM BigDye Terminator Cycle Sequencing Ready Reac-abling interaction of ADA with the A1-adenosine recep-
tion Kit and ABI PRISM 310 Genetic Analyzer were used. PCR was
tor (Ciruela et al., 1996; Franco et al., 1998), which proba- performed in the T3 Thermocycler (Whatman Biometra), with Pfu
bly plays an important role in the ontogenesis of immune polymerase (Stratagene).
tissues. This view would also support the hypothesis by
Ciruela and Franco (Ciruela et al., 1996; Franco et al., Expression of Recombinant Human sDPP-IV in P. pastoris
The ectodomain of DPP-IV, residues 31–766 (sDPP-IV), was ampli-1998), who proposed a link for cell-cell interaction via
fied by PCR with the plasmid pcHDP1-23 as a template (Misumi etthe binding of DPP-IV, ADA, and A1-adenosine.
al., 1992). The oligonucleotides used for PCR were 5-TGCTGGAAT
TCGGCACAGATGATGCTAC-3 with an EcoRI site (bold letters) and
5-GCATGGTACCTT GAGGTGCTAAG -3 with a KpnI site (bold let-Biological Implications
ters). With the two new restriction sites, the amplified DNA fragmentDPP-IV is a serine exopeptidase localized at the plasma
was cloned into pPICZ-A vector (Invitrogen) to create a fusion withmembrane by an N-terminal transmembrane anchor.
the -mating factor signal sequence for the secretion of the protein.Besides its catalytic activity, it has roles in many biologi-
Truncation of the -mating factor by the signal peptidases will leave
cal processes, including binding of adenosine deami- two additional amino acids, glutamine and phenylalanine, at the
nase (Franco et al., 1998), participation in cell matrix N terminus of sDPP-IV. The sequence was confirmed by sequencing.
pPICZ-sDPP-IV was linearized with SacI and transformed by elec-adhesion (Loster et al., 1995; Piazza et al., 1989), interac-
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troporation in P. pastoris strain GS115, and the phenotype of the described by Sterner et al. (1996) with a final protein concentration of
20g/ml in 50 mM potassium phosphate buffer at pH 7.5, containingcolonies obtained was checked as recommended by the distributor,
Invitrogen. 100 mM NaCl. The residual activity was determined by recording
the initial velocity at 25C of the enzyme-catalyzed reaction (seeEight transformants with the phenotype MutS were screened for
the expression of DPP-IV. Colonies were grown at 30C in YPD below), and the averaged values obtained were plotted against the
incubation temperature.medium (1% yeast extract, 2% peptone, and 2% glucose) with zeo-
cin (100 g/ml) to an OD600 of 8–10. Cells were collected by centrifu-
gation and resuspended in YP medium plus 2% methanol. The same Biacore
amount of methanol was added every 24 hr. After 48 hr the medium DPP-IV was immobilized on a CM5 surface plasmon resonance
of each clone was tested for activity (see below). sDPP-IV was then sensor (Biacore) by standard amide coupling chemistry. The organic
produced in a large-scale culture with the transformed cell line with adlayer on this sensor type consists of carboxymethylated dextran
the highest activity per volume, as described (Dale et al., 2000). (MW of 100 kDa). After activation of the carboxylic acid groups
with carbodiimide/N-hydroxysuccinimide solutions, the surface was
contacted with a DPP-IV solution (80 l) containing about 100 g/mlPurification of sDPP-IV
protein in acetate buffer (10 mM [pH 4.5]). The amount immobilizedTen liters of the collected sDPP-IV supernatant of the selected trans-
corresponded to a sensor response of roughly 10,000 RU. The sur-formed P. pastoris cell line was filtered and concentrated to 180
faces of two flow cells were modified with protein. To suppressml by crossflow ultrafiltration (skannette) with a 30 kDaA filtration
baseline drift—possibly due to slow dimer dissociation—the proteinmodule (AGT Technology). The concentrate was passed over a
of one cell was crosslinked by short contact with carbodiimide/Sephacryl 200 XK 50/100 size exclusion column (5  95 cm; Phar-
N-hydroxysuccinimide solution. This treatment did not influence themacia) and equilibrated with 50 mM Tris-HCl (pH 7.8) and 100 mM
protein activity, since binding constants determined with cross-NaCl (S buffer). Collected fractions were screened on SDS-PAGE
linked protein were similar to those determined with noncrosslinkedand for activity. Fractions containing sDPP-IV were dialyzed against
protein. HEPES buffer (0.01 M HEPES [pH 7.4], 0.15 M NaCl, 3 mM50 mM Tris-HCl (pH 7.9). The protein solution was loaded on a
EDTA, and 0.005% polysorbate 20 [v/v]) was used as the runningFractogel-TMAE column (2.6  13 cm; Merck), equilibrated with 50
buffer. Diprotin A was disolved directly in this buffer. NVP-DPP728mM Tris-HCl (pH 7.9), washed with two column volumes of the same
was first dissolved in pure DMSO and then diluted into runningbuffer, and eluted with 500 ml of a linear gradient from 0–200 mM
buffer. The final inhibitor solution contained less than 0.1% DMSO.NaCl. Fractions containing sDPP-IV were dialyzed against 20 mM
Binding experiments were carried out by contacting the immobilizedsodium acetate (pH 4.8). The protein solution was loaded on a Frac-
protein surfaces with inhibitor solutions of varying concentrationstogel-COO column (1  12 cm; Merck), equilibrated with the same
at a flow rate of 10 l/min or 30 l/min. After each contact withbuffer, and washed with two column volumes of this buffer. Bound
inhibitor, the protein surfaces were regenerated by extensivelyproteins were eluted with 200 ml of a linear gradient from 50 to 500
washing with running buffer.M NaCl. The elution profile showed a major peak at 250 mM NaCl.
Preparation of enzymatically deglycosylated sDPP-IV (sDPPIVdeglycos)
was carried out prior to loading on the last gel filtration column. Activity Assay
EndoF1-GST (0.1%) was added to the pooled fractions of DPP-IV The activity assay is based on the increase of fluorescence of prod-
and incubated for 20 hr at 21C. The concentrated protein solution ucts compared to the substrate Ala-Pro-7-amido-4-trifluoromethyl-
was loaded on a Biosec size exclusion column (1.6 60 cm; Merck) coumarin (Calbiochem; Smith et al., 1992). A 20 mM stock solution
that was equilibrated with S buffer. Fractions were analyzed by SDS- in 10% DMF is stored at 20C until use. Purification was followed
PAGE, showing a purity of 95%. N-terminal sequencing showed with a final substrate concentration of 50M, and, for the determina-
that the protein was efficiently processed by the STE13 signal pepti- tion of kinetic parameters, it was varied between 1.5 M and 500
dase, which cleaves off the -mating factor. Preparation of the M in the assay. DPP-IV activity assays were performed in 96-well
sDPPIVdeglycos:ADA complex was performed by addition of a two plates in a total assay volume of 100 l. The assay buffer consists
times excess of ADA (Sigma Type IV, from calf intestinal Mucosa) of S buffer containing 0.1 mg/ml BSA. Fluorescence is detected in
and purification with a Biosec size exclusion column. an LS 50B luminescence spectrometer LS 50B (Perkin Elmer) at an
excitation wavelength of 400 nm and an emission wavelength of 505
nm. Initial rate constants are calculated by best-fit linear regression.Analytical Methods
Purification of sDPP-IV was followed by electrophoresis on 10%–
20% Tricine SDS polyacrylamide gradient gels (La¨mmli, 1970). Pro- Crystallization
tein concentrations were determined according to Bradford (Brad- For crystallization trials, sDPP-IVdeglycos was concentrated to approxi-
ford, 1976) or for pure protein by absorption spectroscopy (Pace et mately 10 mg/ml. A reduced factorial screen was carried out by the
al., 1995) with the calculated molecular extinction coefficient at 280 vapor diffusion method. Crystals were obtained with 20%–25% PEG
nm of 193920 M1cm1 (A280  2.27 for a 1 cm path and a protein 3350, 200 mM MgCl2, Tris (pH 8.5), and 15% glycerol. The crystals
concentration of 1mg/ml). Analytical gel filtration chromatography were flash-frozen in liquid nitrogen and exhibit the orthorhombic
was performed on a Superdex 200 12 HR 10/30 column (Pharmacia) space group P212121, with cell dimensions of approximately 65 A˚,
equilibrated with S buffer. The eluate was monitored with a mini- 68 A˚, and 420 A˚ and one dimer per asymmetric unit. They diffract
DAWN multiangle laser light-scattering detector (Wyatt) and a re- to a maximum of 2.1 A˚ resolution with synchrotron radiation and
fractive index detector (Shodex), which allows the determination of show rather high mosaicity (0.5–1.2). Addition of 1 mM diprotin A
the molecular weight and dispersity over the elution peak (Wyatt, prior to crystallization led to crystals of the complex. The mercury
1993). Sedimentation equilibrium runs in a Beckman analytical ultra- derivative was produced by cocrystallization with 0.1 mM HgCl2.
centrifuge (model Optima XL A) were performed at 20C and 9000
rpm for sDPP-IVdeglycos and at 7000 rpm for the sDPP-IVdeglycos:ADA- Structure Determination
complex. The initial protein concentrations were 0.22–0.25 mg/ml Data collection was performed with synchrotron radiation (Swiss
in S buffer. The absorption was followed at 280 nm. Assumed partial Light Source [SLS], Villigen, Switzerland, and ID14, ESRF, Grenoble,
specific volumes for sDPP-IV of 0.729 cm3/g and ADA of 0.735 cm3/g France) as well as in-house facilities (search for heavy-atom deriva-
were used to determine the molecular masses. tives and evaluation of crystal quality) and processed with DENZO
Free sulfhydryl groups were determined according the procedure (Otwinowski, 1993). Details of the data collection statistics are given
described by Ellman (Ellman, 1959) under denaturing conditions in Table 3. All programs used are part of the CCP4 (CCP4, 1994)
(0.3% SDS in 50 mM Tris [pH 8.0]). suite, except where indicated. The structure was determined by
MAD with a mercury derivative. One major mercury binding site per
subunit (Cys 551, one of the two free SH-groups, Cys301 andThermostability Measurements
The irreversible loss of activity after incubation at various tempera- Cys551, that are located near the active site) was identified by
inspection of the difference Patterson maps calculated from thetures was used as an operational criterion of the thermostability of
sDPP-IV. Kinetics of irreversible heat inactivation were performed as peak wavelength data and was subsequently refined with SHARP
Crystal Structure of DPP-IV
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(de la Fortelle and Bricogne, 1997). Location of the 2-fold noncrys- Davidson, V.L., and Mathews, F.S. (1998). Refined crystal structure
of methylamine dehydrogenase from Paracoccus denitrificans attallographic axis was performed with this mercury site and the pro-
gram find2folds (Dunten and Hennig, 2002). Further analysis re- 1.75 A˚ resolution. J. Mol. Biol. 276, 131–149.
vealed another site per subunit (Cys301), with less occupancy and Ciruela, F., Saura, C., Canela, E.I., Mallol, J., Lluis, C., and Franco,
disorder (two main positions with about 2.4 A˚ distance). Subse- R. (1996). Adenosine deaminase affects ligand-induced signaling
quently, the phases were improved by application of 2-fold averag- by interacting with cell surface adenosine receptors. FEBS Lett.
ing combined with solvent flattening and histogram matching as 380, 219–223.
implemented in DM. The initial electron density at 2.6 A˚ resolution
Cremata, J., Montensino, R., Quintero, O., and Garcia, R. (1998).was readily interpretable, and about 90% of the polypeptide chain
Glycosylation profiling of heterologous proteins. In Pichia Protocols,could be built. The molecular model was refined against 2.1 A˚ data.
D.R. Higgins and J.M. Cregg, eds. (Totowa, New Jersey: HumanaSubsequent rounds of manual rebuilding and refinement with REF-
Press), pp. 95–106.MAC (Murshudov et al., 1999) led to a complete molecular structure
Cunningham, D.F., and O’Connor, B. (1997). Proline specific pepti-of the polypeptide chain from residues Ser39 to Pro766. Details of
dases. Biochim. Biophys. Acta 1343, 160–186.the refined structures are reported in Table 3.
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